{"id":"W2116137820","doi":"10.3747/co.22.2431","title":"An Open-Label Expanded-Access Trial of Bendamustine in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia: BEND-ACT","year":2015,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Manitoba; University of Calgary; Hôpital de l'Enfant-Jésus; Dalhousie University; University of Toronto; McMaster University; Université du Québec à Montréal; Juravinski Cancer Centre","funders":"National Cancer Institute; Lundbeck Canada","keywords":"Bendamustine; Medicine; Tolerability; Neutropenia; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Adverse effect; Nausea; Refractory (planetary science); Oncology; Lymphoma; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001989547,0.001262236,0.001305974,0.0003084021,0.0003399438,0.0007969904,0.0007133767,0.001256698,0.006259433],"category_scores_gemma":[0.001026837,0.0003623016,0.0007292288,0.000294564,0.001016661,0.000987076,0.0004621329,0.002401151,0.000820453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000737429,"about_ca_system_score_gemma":0.001172466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006221416,"about_ca_topic_score_gemma":0.001717982,"domain_scores_codex":[0.9993279,0.0004159544,0.00002747425,0.000085659,0.00004306458,0.00009993477],"domain_scores_gemma":[0.9990037,0.0002499092,0.0002001063,0.0000748279,0.0000530586,0.0004184254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9457639,0.02202743,0.003170494,0.0002295467,0.0003531814,0.00009742846,0.0001129631,0.0004081573,0.005756163,0.0001269239,0.0007969196,0.02115677],"study_design_scores_gemma":[0.7511191,0.2387773,0.006674038,0.00001942169,0.000170556,0.0001210774,0.00003013396,0.0004700048,0.0008900032,0.0001104264,0.001604489,0.00001347322],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932422,0.001189155,0.0002927648,0.0002638983,0.00007920152,0.002269613,0.0007252307,0.00004757463,0.001890309],"genre_scores_gemma":[0.9909033,0.000770879,0.00106936,0.0006461299,0.0002470968,0.002609717,0.001832219,0.00001514928,0.001906054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006259433,"threshold_uncertainty_score":0.02093995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1706744940988884,"score_gpt":0.4602888018471838,"score_spread":0.2896143077482954,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}